Try our Advanced Search for more refined results
December 11, 2012
ENDO PHARMACEUTICALS INC. v. ACTAVIS INC. et al
Case Number:
2:12-cv-07591
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 14, 2016
Endo's False Ad Claims Against Actavis Tossed For Good
A New Jersey federal judge on Tuesday dismissed with prejudice Endo Pharmaceuticals Inc.'s false marketing lawsuit against Actavis Inc. in the wake of a related patent infringement judgment in New York federal court that bars Actavis from selling a generic version of Endo's painkiller Opana ER.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login